Publications of Florian Holsboer
All genres
Conference Paper (1)
941.
Conference Paper
83 (9, Suppl.), S74, pp. S375 - S376 (2018)
Perspective of Personalized Drug Treatment in Depression. 73rd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), New York, NY, May 10, 2018 - May 12, 2018. BIOLOGICAL PSYCHIATRY Meeting Abstract (16)
942.
Meeting Abstract
28, p. i314 - i314. (2025)
GENOMIC AND IMMUNOLOGICAL BIOMARKERS FOR PREDICTING TREATMENT OUTCOME IN DEPRESSION. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 943.
Meeting Abstract
21 (10), pp. 766 - 774. (2020)
Evidence for an enhanced procoagulant state in remitted major depression. In WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 944.
Meeting Abstract
29, pp. S46 - S47. 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, SPAIN, October 06, 2018 - October 09, 2018. (2019)
Perspective of personalised drug treatment in depression. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 945.
Meeting Abstract
88, p. 134 - 134. 25th World Congress of the
International-College-of-Psychosomatic-Medicine (ICPM) on Psychosomatic
Medicine, Florence, ITALY, September 11, 2019 - September 13, 2019. (2019)
Evidence for an enhanced procoagulant state in remitted major depression. In PSYCHOTHERAPY AND PSYCHOSOMATICS, 946.
Meeting Abstract
61 Special Issue Ed., PO94, p. 56 - 56. 45th Annual Meeting of the International-Society-of-Psychoneuroendocrinology (ISPNE) on Stress and
the Brain - From Fertility to Senility, Edinburgh, SCOTLAND, September 08, 2015 - September 11, 2015. Elsevier BV, Amsterdam (2015)
Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: A translational approach. In PSYCHONEUROENDOCRINOLOGY, 947.
Meeting Abstract
25 (Supplement 2), P.1.e.016, p. S218 - S218. 28th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Amsterdam, NETHERLANDS, August 29, 2015 - September 01, 2015. Elsevier Science B.V., Amsterdam, NL (2015)
Dexamethasone plasma levels impact glucocorticoid receptors-challenge tests for detection of HPA-axis alterations. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 948.
Meeting Abstract
10 (4), p. 718 - 718. Purines 2014, International Conference on Nucleotides, Nucleosides and Nucleobases, Bonn, July 23, 2014 - July 29, 2014. Springer, Dordrecht, NL (2014)
P2RX7-a susceptibility gene for mood disorders? In PURINERGIC SIGNALLING, 949.
Meeting Abstract
17, RA-01-003, p. 42 - 42. 29th CINP World Congress of Neuropsychopharmacology
, Vancouver, Canada, June 22, 2014 - June 26, 2014. Oxford University Press, Oxford, UK (2014)
Genetic predictor of antidepressant response for major depressive disorder accounting for clinical subgroups: A genome-wide association study. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 950.
Meeting Abstract
75 (9), p. 23S - 23S. 69th Annual Scientific Convention and Meeting of the
Society-of-Biological-Psychiatry, New York, NY, May 08, 2014 - May 10, 2014. Elsevier Science Inc., New York, NY, USA (2014)
ABCB1 Genotyping Informs the Clinician About Adequacy of Antidepressant Dosing. In BIOLOGICAL PSYCHIATRY, 951.
Meeting Abstract
75 (9), p. 311S - 311S. 69th Annual Scientific Convention and Meeting of the
Society-of-Biological-Psychiatry, New York, NY. Elsevier Science Inc., New York, NY, USA (2014)
FKBP5 Critically Impacts Antidepressant Action and Recovery from Chronic Stress. In BIOLOGICAL PSYCHIATRY, 952.
Meeting Abstract
75 (9), p. 23S - 23S. 69th Annual Scientific Convention and Meeting of the
Society-of-Biological-Psychiatry, New York, NY, May 08, 2014 - May 10, 2014. Elsevier Science Inc., New York, NY, USA (2014)
ABCB1 Genetics and Function Determine Penetrance of Antidepressants Into the Brain: Treatment Implications and Open Research Questions. In BIOLOGICAL PSYCHIATRY, 953.
Meeting Abstract
75 (9), pp. 113S - 114S. 69th Annual Scientific Convention and Meeting of the
Society-of-Biological-Psychiatry, New York, NY, May 08, 2014 - May 10, 2014. Elsevier Science Inc., New York, NY, USA (2014)
Dexamethasone Plasma Levels Increase the Sensitivity of GR-Challenge Tests to Detect HPA-Axis Alterations. In BIOLOGICAL PSYCHIATRY, 954.
Meeting Abstract
75 (9), p. 45S - 45S. 69th Annual Scientific Convention and Meeting of the
Society-of-Biological-Psychiatry, New York, NY, May 08, 2014 - May 10, 2014. Elsevier Science Inc., New York, NY, USA (2014)
RNA Expression Profiling in Age-/Severity-Matched Depressed Inpatients Revealed New Candidates as Possible Biomarkers for Antidepressant Response. In BIOLOGICAL PSYCHIATRY, 955.
Meeting Abstract
73 (9), 747, p. 239S - 239S. 68th Annual Scientific Meeting of the Society-of-Biological-Psychiatry, San Francisco, CA, May 16, 2013 - May 18, 2013. (2013)
Recurrent Depression is Associated with Earlier Ocurrence of Metabolic Syndrome and Aggravates the Effect of Vascular Risk Factors on Cerebral Microangiopathy Determined By MRI. In Biological Psychiatry, 956.
Meeting Abstract
73 (9), p. 15S - 15S. 68th Annual Scientific Meeting of the Society-of-Biological-Psychiatry, San Francisco, CA, May 16, 2013 - May 18, 2013. Elsevier Inc., New York, NY 10010-1710 (2013)
Epigenetic Modification as Mediator of Gene-Childhood Trauma Interactions. In BIOLOGICAL PSYCHIATRY, 957.
Meeting Abstract
73 (9), p. 204S - 204S. ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA (2013)
The Impact of Weight on Differential Alterations of GR-Mediated FKBP5. In BIOLOGICAL PSYCHIATRY, Thesis - Habilitation (1)
958.
Thesis - Habilitation
Zur Steroidsekretion bei depressiven Patienten und bei sexueller Dysfunktion. Habilitation, Johannes-Gutenberg-Universität, Mainz (1984)
Book Review (1)
959.
Book Review
Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System-V1b-antagonists as a Case in Point. PHARMACOPSYCHIATRY (2024)